Literature DB >> 9339283

First case of surgical treatment of Farber's disease.

G Haraoka1, M Muraoka, N Yoshioka, S Wakami, I Hayashi.   

Abstract

Farber's disease (Farber's lipogranulomatosis), which is inherited as an autosomal recessive trait, was first reported by Farber in 1952. We report a case of Farber's disease in a 12-year-old female. Her younger brother was affected with Farber's disease and died of it at 2 years of age. When she first presented, our patient's main clinical features were a shrill voice; subcutaneous nodules; contracture of the joints throughout the body; and granulomas of the oral cavity, the pharynx, and the upper and lower eyelids. Serial radiographs disclosed deformation of the joints throughout the body. Due to the granulomas in her oral cavity, she could take little food orally and therefore was malnourished. We performed a granulectomy under general anesthesia, and her difficulty with feeding and upper airway obstruction improved. There is no specific treatment for Farber's disease, and most patients reported have died by 2 years of age. This is the first reported patient with Farber's disease who has been surgically treated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9339283     DOI: 10.1097/00000637-199710000-00011

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

1.  Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.

Authors:  Jagdeep S Walia; Anton Neschadim; Orlay Lopez-Perez; Abdulfatah Alayoubi; Xin Fan; Stéphane Carpentier; Melissa Madden; Chyan-Jang Lee; Fred Cheung; David A Jaffray; Thierry Levade; J Andrea McCart; Jeffrey A Medin
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

2.  In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.

Authors:  Shobha Ramsubir; Takahiro Nonaka; Carmen Bedia Girbés; Stéphane Carpentier; Thierry Levade; Jeffrey A Medin
Journal:  Mol Genet Metab       Date:  2008-09-20       Impact factor: 4.797

3.  Applying MetaMap to Medline for identifying novel associations in a large clinical dataset: a feasibility analysis.

Authors:  David A Hanauer; Mohammed Saeed; Kai Zheng; Qiaozhu Mei; Kerby Shedden; Alan R Aronson; Naren Ramakrishnan
Journal:  J Am Med Inform Assoc       Date:  2014-06-13       Impact factor: 4.497

Review 4.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

Review 5.  Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.

Authors:  Farzana Parveen; Daniel Bender; Shi-Hui Law; Vineet Kumar Mishra; Chih-Chieh Chen; Liang-Yin Ke
Journal:  Cells       Date:  2019-12-04       Impact factor: 6.600

6.  Systemic ceramide accumulation leads to severe and varied pathological consequences.

Authors:  Abdulfatah M Alayoubi; James C M Wang; Bryan C Y Au; Stéphane Carpentier; Virginie Garcia; Shaalee Dworski; Samah El-Ghamrasni; Kevin N Kirouac; Mathilde J Exertier; Zi Jian Xiong; Gilbert G Privé; Calogera M Simonaro; Josefina Casas; Gemma Fabrias; Edward H Schuchman; Patricia V Turner; Razqallah Hakem; Thierry Levade; Jeffrey A Medin
Journal:  EMBO Mol Med       Date:  2013-05-16       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.